L. Bevan

发表

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke ( RIGHT-2 ) : an ambulance-based , randomised , sham-controlled , blinded , phase 3 trial

Peter J. Godolphin, P. Sandercock, C. Anderson, 2019 .

The pneumonectomy model of compensatory lung growth: insights into lung regeneration.

Carina Gross, L. Bevan, K. Choy, 2014, Pharmacology & therapeutics.

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

A. Stamatoullas, S. Chevret, E. Wattel, 2019, Haematologica.

Notch2 is required for inflammatory cytokine-driven goblet cell metaplasia in the lung.

Amy Y. Chen, Marc Hild, Arno Doelemeyer, 2015, Cell reports.

ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERK

C. Murray, V. Berdini, J. Lyons, 2021, Molecular Cancer Therapeutics.

Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2.

C. Murray, V. Berdini, L. Fazal, 2021, Journal of medicinal chemistry.

3D Reconstruction of the Human Airway Mucosa In Vitro as an Experimental Model to Study NTHi Infections

Marco Soriani, M. Soriani, J. Telford, 2016, PloS one.

Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein Interaction.

M. Noble, J. Endicott, G. Chessari, 2021, Journal of medicinal chemistry.

Results of a Phase II Study of Guadecitabine (SGI-110) in Higher Risk MDS, CMML or Low Blast Count AML Patients Refractory to or Relapsing after Azacitidine (AZA) Treatment

A. Stamatoullas, S. Chevret, E. Wattel, 2016 .